Changes in heart rate dynamics of patients with schizophrenia treated with risperidone

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 6, 2010, Pages 924-929

  Chang, Jae Seung ^a   Yoo, Cheol Sung ^b   Yi, Sang Hoon ^c   Hong, Kye Hyun ^d   Lee, Yu Sang ^e   Oh, Hong Seok ^e   Jung, Dong Chung ^f   Kim, Yong Sik ^b,f   Ahn, Yong Min ^b,f  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Inje University   (South Korea)

^d Keyo Hospital   (South Korea)

^e Yong in Mental Hospital   (South Korea)

^f Seoul National University Hospital   (South Korea)

Author keywords

Heart rate variability; Risperidone; Schizophrenia; Sympathovagal balance

Indexed keywords

RISPERIDONE; NEUROLEPTIC AGENT;

ACUTE DISEASE; ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INDUCED EXTRAPYRAMIDAL SYMPTOMS SCALE; ELECTROCARDIOGRAPHY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEART RATE VARIABILITY; HUMAN; MALE; NEUROLOGIC EXAMINATION; NEUROMODULATION; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHIZOPHRENIA; VAGUS NERVE STIMULATION; ADRENERGIC SYSTEM; ANALYSIS OF VARIANCE; DRUG EFFECT; HEART RATE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; CLUSTER ANALYSIS; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; RISPERIDONE; SCHIZOPHRENIA; SYMPATHETIC NERVOUS SYSTEM; TREATMENT OUTCOME;

EID: 78049443965     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.04.017     Document Type: Article

References (53)

1. Agelink M.W., Majewski T., Wurthmann C., Lukas K., Ullrich H., Linka T., et al. Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine. J Clin Psychopharmacol 2001, 21:8-13.
2. Agelink M.W., Sayar K., Klieser E. Usefulness of heart rate variability (HRV) for monitoring clozapine plasma levels. Pharmacopsychiatry 2003, 36:166-167. authors reply 8.
3. Aldenderfer M.S., Blashfield R.K. Cluster analysis 1984, Sage Publications, Newbury Park, CA.
4. Bär K.J., Berger S., Metzner M., Boettger M.K., Schulz S., Ramachandraiah C.T., et al. Autonomic dysfunction in unaffected first-degree relatives of patients suffering from schizophrenia. Schizophr Bull 2009.
5. Bär K.J., Boettger M.K., Koschke M., Schulz S., Chokka P., Yeragani V.K., et al. Non-linear complexity measures of heart rate variability in acute schizophrenia. Clin Neurophysiol 2007, 118:2009-2015.
6. Bär K.J., Boettger M.K., Schulz S., Harzendorf C., Agelink M.W., Yeragani V.K., et al. The interaction between pupil function and cardiovascular regulation in patients with acute schizophrenia. Clin Neurophysiol 2008, 119:2209-2213.
7. Bär K.J., Koschke M., Berger S., Schulz S., Tancer M., Voss A., et al. Influence of olanzapine on QT variability and complexity measures of heart rate in patients with schizophrenia. J Clin Psychopharmacol 2008, 28:694-698.
8. Bär K.J., Koschke M., Boettger M.K., Berger S., Kabisch A., Sauer H., et al. Acute psychosis leads to increased QT variability in patients suffering from schizophrenia. Schizophr Res 2007, 95:115-123.
9. Bär K.J., Letzsch A., Jochum T., Wagner G., Greiner W., Sauer H. Loss of efferent vagal activity in acute schizophrenia. J Psychiatr Res 2005, 39:519-527.
10. Bär K.J., Wernich K., Boettger S., Cordes J., Boettger M.K., Loffler S., et al. Relationship between cardiovagal modulation and psychotic state in patients with paranoid schizophrenia. Psychiatry Res 2008, 157:255-257.
11. Boettger S., Hoyer D., Falkenhahn K., Kaatz M., Yeragani V.K., Bär K.J. Altered diurnal autonomic variation and reduced vagal information flow in acute schizophrenia. Clin Neurophysiol 2006, 117:2715-2722.
12. Chang J.S., Ahn Y.M., Park H.J., Lee K.Y., Kim S.H., Kang U.G., et al. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2008, 69:720-731.
13. Chang J.S., Yi J.S., Ahn Y.M., Kim J.H., Kim Y.S. Stabilization of the internal structure of persistent auditory verbal hallucinations in schizophrenia. Aust NZ J Psychiatry 2009, 43:244-251.
14. Chang J.S., Yoo C.S., Yi S.H., Hong K.H., Oh H.S., Hwang J.Y., et al. Differential pattern of heart rate variability in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:991-995.
15. Cohen H., Loewenthal U., Matar M., Kotler M. Association of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication. Br J Psychiatry 2001, 179:167-171.
16. Cohen J. Statistical power analysis for the behavioral sciences 1988, Lawrence Earlbaum Associates, Hillsdale, NJ. 2nd.
17. Eschweiler G.W., Bartels M., Langle G., Wild B., Gaertner I., Nickola M. Heart-rate variability (HRV) in the ECG trace of routine EEGs: fast monitoring for the anticholinergic effects of clozapine and olanzapine?. Pharmacopsychiatry 2002, 35:96-100.
18. Guy W. Assessment manual for psychopharmacology, Revised. Bethesda, Md: US Dept of Health, Education and Welfare 1976, National Institute of Mental Health.
19. Hautala A.J., Karjalainen J., Kiviniemi A.M., Kinnunen H., Makikallio T.H., Huikuri H.V., et al. Physical activity and heart rate variability measured simultaneously during waking hours. Am J Physiol Heart Circ Physiol 2010, 298:H874-H880.
20. Hempel R., Tulen J., van Beveren N., Roder C., Hengeveld M. Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia. J Psychopharmacol 2009, 23:697-707.
21. Hennekens C.H., Hennekens A.R., Hollar D., Casey D.E. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005, 150:1115-1121.
22. Huikuri H.V., Makikallio T.H., Peng C.K., Goldberger A.L., Hintze U., Moller M. Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation 2000, 101:47-53.
23. Inada T. Evaluation and diagnosis of drug-induced extrapyramidal symptoms: commentary on the DIEPSS and guide to its usage 1996, Seiwa Shoten Publishers, Tokyo.
24. Jindal R., MacKenzie E.M., Baker G.B., Yeragani V.K. Cardiac risk and schizophrenia. J Psychiatry Neurosci 2005, 30:393-395.
25. Jindal R.D., Keshavan M.S., Eklund K., Stevens A., Montrose D.M., Yeragani V.K. Beat-to-beat heart rate and QT interval variability in first episode neuroleptic-naive psychosis. Schizophr Res 2009, 113:176-180.
26. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
27. Kim J.H., Yi S.H., Ahn Y.M., Lee K.Y., Yang S.A., Kim Y.S. The pNNx heart rate variability statistics: an application to neuroautonomic dysfunction of clozapine-treated subjects. Psychiatry Investig 2009, 6:294-298.
28. Kim J.H., Yi S.H., Park K.T., Ahn Y.M., Lee K.Y., Yang S.A., et al. Diminished neurocardiac dynamics associated with antipsychotic-induced extrapyramidal syndrome. Eur Neuropsychopharmacol 2006, 16:459-463.
29. Kim J.H., Yi S.H., Yoo C.S., Yang S.A., Yoon S.C., Lee K.Y., et al. Heart rate dynamics and their relationship to psychotic symptom severity in clozapine-treated schizophrenic subjects. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:371-378.
30. Koponen H., Alaraisanen A., Saari K., Pelkonen O., Huikuri H., Raatikainen M.J., et al. Schizophrenia and sudden cardiac death: a review. Nord J Psychiatry 2008, 62:342-345.
31. Mackowiak M., Dudys D., Chocyk A., Wedzony K. Repeated risperidone treatment increases the expression of NCAM and PSA-NCAM protein in the rat medial prefrontal cortex. Eur Neuropsychopharmacol 2009, 19:125-137.
32. Mann K., Rossbach W., Muller M.J., Muller-Siecheneder F., Ru H., Dittmann R.W. Heart rate variability during sleep in patients with schizophrenia treated with olanzapine. Int Clin Psychopharmacol 2004, 19:325-330.
33. Massin M.M., Derkenne B., von Bernuth G. Correlations between indices of heart rate variability in healthy children and children with congenital heart disease. Cardiology 1999, 91:109-113.
34. McNamara R.K., Able J.A., Jandacek R., Rider T., Tso P. Chronic risperidone treatment preferentially increases rat erythrocyte and prefrontal cortex omega-3 fatty acid composition: evidence for augmented biosynthesis. Schizophr Res 2009, 107:150-157.
35. Mietus J.E., Peng C.K., Henry I., Goldsmith R.L., Goldberger A.L. The pNNx files: re-examining a widely used heart rate variability measure. Heart 2002, 88:378-380.
36. Mujica-Parodi L.R., Yeragani V., Malaspina D. Nonlinear complexity and spectral analyses of heart rate variability in medicated and unmedicated patients with schizophrenia. Neuropsychobiology 2005, 51:10-15.
37. Nolan J., Batin P.D., Andrews R., Lindsay S.J., Brooksby P., Mullen M., et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 1998, 98:1510-1516.
38. Peupelmann J., Boettger M.K., Ruhland C., Berger S., Ramachandraiah C.T., Yeragani V.K., et al. Cardio-respiratory coupling indicates suppression of vagal activity in acute schizophrenia. Schizophr Res 2009, 112:153-157.
39. Peupelmann J., Quick C., Berger S., Hocke M., Tancer M.E., Yeragani V.K., et al. Linear and non-linear measures indicate gastric dysmotility in patients suffering from acute schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:1236-1240.
40. Pincus S., Singer B.H. Randomness and degrees of irregularity. Proc Natl Acad Sci U S A 1996, 93:2083-2088.
41. Porta A., Baselli G., Guzzetti S., Pagani M., Malliani A., Cerutti S. Prediction of short cardiovascular variability signals based on conditional distribution. IEEE Trans Biomed Eng 2000, 47:1555-1564.
42. Ray W.A., Chung C.P., Murray K.T., Hall K., Stein C.M. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009, 360:225-235.
43. Rechlin T., Beck G., Weis M., Kaschka W.P. Correlation between plasma clozapine concentration and heart rate variability in schizophrenic patients. Psychopharmacology (Berl) 1998, 135:338-341.
44. Richman J.S., Moorman J.R. Physiological time-series analysis using approximate entropy and sample entropy. Am J Physiol Heart Circ Physiol 2000, 278:H2039-H2049.
45. Silke B., Campbell C., King D.J. The potential cardiotoxicity of antipsychotic drugs as assessed by heart rate variability. J Psychopharmacol 2002, 16:355-360.
46. Straus S.M., Bleumink G.S., Dieleman J.P., van der Lei J., t Jong G.W., Kingma J.H., et al. Antipsychotics and the risk of sudden cardiac death. Arch Intern Med 2004, 164:1293-1297.
47. Thayer J.F., Lane R.D. Claude Bernard and the heart-brain connection: further elaboration of a model of neurovisceral integration. Neurosci Biobehav Rev 2009, 33:81-88.
48. Toichi M., Kubota Y., Murai T., Kamio Y., Sakihama M., Toriuchi T., et al. The influence of psychotic states on the autonomic nervous system in schizophrenia. Int J Psychophysiol 1999, 31:147-154.
49. Valkonen-Korhonen M., Tarvainen M.P., Ranta-Aho P., Karjalainen P.A., Partanen J., Karhu J., et al. Heart rate variability in acute psychosis. Psychophysiology 2003, 40:716-726.
50. von Borell E., Langbein J., Despres G., Hansen S., Leterrier C., Marchant-Forde J., et al. Heart rate variability as a measure of autonomic regulation of cardiac activity for assessing stress and welfare in farm animals-a review. Physiol Behav 2007, 92:293-316.
51. Wang Y.C., Yang C.C., Bai Y.M., Kuo T.B. Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine. 3-month follow-up. Neuropsychobiology 2008, 57:200-205.
52. Williams L.M., Das P., Harris A.W., Liddell B.B., Brammer M.J., Olivieri G., et al. Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am J Psychiatry 2004, 161:480-489.
53. Yeragani V.K., Rao R., Jayaraman A., Pohl R., Balon R., Glitz D. Heart rate time series: decreased chaos after intravenous lactate and increased non-linearity after isoproterenol in normal subjects. Psychiatry Res 2002, 109:81-92.